Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

1005630

registered interest
date	12/11/2018
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Business: Investment
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Baroness Neville-Rolfe on 4 April 2017 (HL6630), what assessment they have made of the ONS release, Business Investment in the UK: April to June 2018 revised results, which showed that business investment fell by 0.2 per cent in the last quarter and by 0.7 percent compared to a year earlier; and, in the light of that release, whether they still expect that by 2021 business investment will (1) grow by 15 per cent, and (2) rise as a share of GDP.
tabling member printed	Lord Mendelsohn
uin	HL11401
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>We have made no specific assessment of this release.</p><p>In the 2018 Budget, the Government announced measures that are expected to affect business investment. These include the introduction of a permanent structures and buildings allowance and a temporary increase in the annual investment allowance for 2 years. These measures, in conjunction with the reduction in the writing down allowance for the special rate pool of assets are expected to increase the level of business investment by 0.4 per cent by the end of the forecast period.</p><p>In its October 2018 forecast, the independent OBR (Office for Budget Responsibility) expect business investment to increase by 8% between 2016 Q4 and 2021Q1 and for business investment to rise as a share of GDP.</p> answering member printed Lord Bates question first answered 26/11/2018 15:52:40 answering member 1091 label Biography information for Lord Bates
tabling member	4286 label Biography information for Lord Mendelsohn

1005631

registered interest
date	12/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the level of spending on treatment for and research into blood cancer in other countries compared to the UK.
tabling member printed	Lord Mendelsohn
uin	HL11402
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>NHS England does not hold information on the level of spending on blood cancer treatment in other countries.</p> answering member printed Lord O'Shaughnessy question first answered 26/11/2018 13:00:38 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4286 label Biography information for Lord Mendelsohn

1005632

registered interest
date	12/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Expenditure
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 5 November (HL10893), what data they hold on on the amount spent by the NHS on (1) treatment, and (2) drugs for different health conditions.
tabling member printed	Lord Mendelsohn
uin	HL11403
answer	answer is ministerial correction date of answer 26/11/2018 answer text <p>The information is not collected centrally in the format requested.</p><p>NHS Improvement collect and publish reference costs data which are the average unit cost to the National Health Service of providing defined services to NHS patients in England in a given financial year rather than the total amount spent on treatment.</p><p>As a subset of these reference costs, data is collected about high cost drugs only.</p> answering member printed Lord O'Shaughnessy question first answered 26/11/2018 13:01:30 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4286 label Biography information for Lord Mendelsohn